What is the role of the EDA community in future life science breakthroughs?
TimeWednesday, July 13th10:30am - 12pm PDT
Location3001, Level 3
DescriptionBiological processes are rapidly becoming better understood. In fact, there is now an increasing application of computational methods to solve several biological processes — from COVID-19 predictions to genome sequencing to drug and vaccine development. Synthetic biology has seen a convergence of chip design and biology. Therefore, it stands to reason that electronic design automation should be a natural contributor to this growth, in both the synthetic biology space, as well as skill and knowledge transfer from electronics design problems to biology problems. However, there continue to be barriers to entry for this convergence. This panel will discuss how the EDA community can get involved. Key topics to be discussed include technological challenges (especially at the interface between electronics and biology), applications wherein there exists a value-added proposition of a hybrid electronic/biological system, challenges for large scale deployment of such systems for expedited diagnostics and/or drug/vaccine development, applying knowledge and skills from already solved electronic problems to biology problems and questions related to ethical issues as well as privacy/security in such systems.